Yukun Duan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yukun Duan has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Bin Liu
Department of Chemical and Biomolecular Engineering National University of Singapore Singapore Singapore
14 shared publications - Wenbo Wu
Tianjin University
6 shared publications Chi Uyen Phan
Department of Chemistry Zhejiang University Hangzhou 310028 P. R. China
3 shared publications- Guping Tang
State Key Laboratory of Swine and Poultry Breeding Industry, College of Animal Science and Technology, Sichuan Agricultural University, Chengdu, China
3 shared publications Min Wu
Department of Chemical and Biomolecular Engineering National University of Singapore 4 Engineering Drive 4 Singapore 117585 Singapore
3 shared publications- Min Wu
Department of Chemical and Biomolecular Engineering National University of Singapore 4 Engineering Drive 4 Singapore 117585 Singapore
3 shared publications
Latest Publications
- 25 January 2022
- Published by Wiley in Advanced Materials
- Vol. 34 (13) , 2109010
Direct Synthesis of Photosensitizable Bacterial Cellulose as Engineered Living Material for Skin Wound Repair
Living materials based on bacterial cellulose (BC) represent a natural and promising candidate for wound dressing. Both physical adsorption and chemical methods have been applied to BC for realizing antibacterial function. However, effective and long‐lasting incorporation of bactericidal moieties to BC remains challenging. Herein, a Komagataeibacter sucrofermentans‐based direct synthetic method to fabricate photosensitizer‐grafted BC through in situ bacterial metabolism in the presence of TPEPy‐modified glucose is explored. The results verify that the direct biosynthesis method is efficient and convenient to endow BC with outstanding fluorescence and light‐triggered photodynamic bactericidal activity for skin wound repair. This work presents a new approach to fabricate eco‐friendly and active wound dressing with light‐controlled bactericidal activity by microbial metabolism. The successful modification of the glucose carbon source of microorganisms also offers insights for biosyntheses of other living materials through microbial metabolism.
- 25 January 2022
- Published by Wiley in Advanced Materials
- Vol. 34 (13) , 2109010
Direct Synthesis of Photosensitizable Bacterial Cellulose as Engineered Living Material for Skin Wound Repair
Living materials based on bacterial cellulose (BC) represent a natural and promising candidate for wound dressing. Both physical adsorption and chemical methods have been applied to BC for realizing antibacterial function. However, effective and long‐lasting incorporation of bactericidal moieties to BC remains challenging. Herein, a Komagataeibacter sucrofermentans‐based direct synthetic method to fabricate photosensitizer‐grafted BC through in situ bacterial metabolism in the presence of TPEPy‐modified glucose is explored. The results verify that the direct biosynthesis method is efficient and convenient to endow BC with outstanding fluorescence and light‐triggered photodynamic bactericidal activity for skin wound repair. This work presents a new approach to fabricate eco‐friendly and active wound dressing with light‐controlled bactericidal activity by microbial metabolism. The successful modification of the glucose carbon source of microorganisms also offers insights for biosyntheses of other living materials through microbial metabolism.
- 28 July 2021
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 33 (15) , 5974-5980
Metabolizable Photosensitizer with Aggregation-Induced Emission for Photodynamic Therapy
- 28 July 2021
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 33 (15) , 5974-5980
Metabolizable Photosensitizer with Aggregation-Induced Emission for Photodynamic Therapy
- 20 October 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (6) , 3212-3218
AIEgen‐Lipid Conjugate for Rapid Labeling of Neutrophils and Monitoring of Their Behavior
Studies on neutrophil‐based nanotherapeutic engineering have shown great potentials in treating infection and inflammation disorders. Conventional neutrophil labeling methods are time‐consuming and often result in undesired contamination and activation since neutrophils are terminal‐differentiated cells with a half‐life span of only 7 h. A simple, fast, and biocompatible strategy to construct engineered neutrophils is highly desirable but remains difficult to achieve. In this study, we present an AIEgen‐lipid conjugate, which can efficiently label harvested neutrophils in 30 s with no washing step required. This fast labeling method does not affect the activation and transmigration property of neutrophils, which has been successfully used to monitor neutrophil behaviors such as the chemotaxis process and migrating function towards inflammation sites both in vitro and in vivo, offering a tantalizing prospect for neutrophil‐based nanotherapeutics studies.
- 20 October 2020
- Published by Wiley in Angewandte Chemie
- Vol. 133 (6) , 3212-3218
AIEgen‐Lipid Conjugate for Rapid Labeling of Neutrophils and Monitoring of Their Behavior
Studies on neutrophil‐based nanotherapeutic engineering have shown great potentials in treating infection and inflammation disorders. Conventional neutrophil labeling methods are time‐consuming and often result in undesired contamination and activation since neutrophils are terminal‐differentiated cells with a half‐life span of only 7 h. A simple, fast, and biocompatible strategy to construct engineered neutrophils is highly desirable but remains difficult to achieve. In this study, we present an AIEgen‐lipid conjugate, which can efficiently label harvested neutrophils in 30 s with no washing step required. This fast labeling method does not affect the activation and transmigration property of neutrophils, which has been successfully used to monitor neutrophil behaviors such as the chemotaxis process and migrating function towards inflammation sites both in vitro and in vivo, offering a tantalizing prospect for neutrophil‐based nanotherapeutics studies.
- 20 October 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (6) , 3175-3181
AIEgen‐Lipid Conjugate for Rapid Labeling of Neutrophils and Monitoring of Their Behavior
Studies on neutrophil‐based nanotherapeutic engineering have shown great potentials in treating infection and inflammation disorders. Conventional neutrophil labeling methods are time‐consuming and often result in undesired contamination and activation since neutrophils are terminal‐differentiated cells with a half‐life span of only 7 h. A simple, fast, and biocompatible strategy to construct engineered neutrophils is highly desirable but remains difficult to achieve. In this study, we present an AIEgen‐lipid conjugate, which can efficiently label harvested neutrophils in 30 s with no washing step required. This fast labeling method does not affect the activation and transmigration property of neutrophils, which has been successfully used to monitor neutrophil behaviors such as the chemotaxis process and migrating function towards inflammation sites both in vitro and in vivo, offering a tantalizing prospect for neutrophil‐based nanotherapeutics studies.
- 20 October 2020
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (6) , 3175-3181
AIEgen‐Lipid Conjugate for Rapid Labeling of Neutrophils and Monitoring of Their Behavior
Studies on neutrophil‐based nanotherapeutic engineering have shown great potentials in treating infection and inflammation disorders. Conventional neutrophil labeling methods are time‐consuming and often result in undesired contamination and activation since neutrophils are terminal‐differentiated cells with a half‐life span of only 7 h. A simple, fast, and biocompatible strategy to construct engineered neutrophils is highly desirable but remains difficult to achieve. In this study, we present an AIEgen‐lipid conjugate, which can efficiently label harvested neutrophils in 30 s with no washing step required. This fast labeling method does not affect the activation and transmigration property of neutrophils, which has been successfully used to monitor neutrophil behaviors such as the chemotaxis process and migrating function towards inflammation sites both in vitro and in vivo, offering a tantalizing prospect for neutrophil‐based nanotherapeutics studies.
- 20 October 2020
- Published by Wiley in Advanced Materials
- Vol. 32 (47) , e2005222
HClO‐Activated Fluorescence and Photosensitization from an AIE Nanoprobe for Image‐Guided Bacterial Ablation in Phagocytes
Bacteria hiding in host phagocytes are difficult to kill, which can cause phagocyte disorders resulting in local and systemic tissue damage. Effective accumulation of activatable photosensitizers (PSs) in phagocytes to realize selective imaging and on‐demand photodynamic ablation of bacteria is of great scientific and practical interests for precise bacteria diagnosis and treatment. Herein, HClO‐activatable theranostic nanoprobes, DTF‐FFP NPs, for image‐guided bacterial ablation in phagocytes are introduced. DTF‐FFP NPs are prepared by nanoprecipitation of an HClO‐responsive near‐infrared molecule FFP and an efficient PS DTF with aggregation‐induced emission characteristic using an amphiphilic polymer Pluronic F127 as the encapsulation matrix. As an energy acceptor, FFP can quench both fluorescence and production of reactive oxygen species (ROS) of DTF, thus eliminating the phototoxicity of DTF‐FFP NPs in normal cells and tissues. Once delivered to the infection sites, DTF‐FFP NPs light up with red fluorescence and efficiently generate ROS owing to the degradation of FFP by the stimulated release of HClO in phagocytes. The selective activation of fluorescence and photosensitization is successfully confirmed by both in vitro and in vivo results, demonstrating the effectiveness and theranostic potential of DTF‐FFP NPs in precise bacterial therapy.
- 20 October 2020
- Published by Wiley in Advanced Materials
- Vol. 32 (47) , e2005222
HClO‐Activated Fluorescence and Photosensitization from an AIE Nanoprobe for Image‐Guided Bacterial Ablation in Phagocytes
Bacteria hiding in host phagocytes are difficult to kill, which can cause phagocyte disorders resulting in local and systemic tissue damage. Effective accumulation of activatable photosensitizers (PSs) in phagocytes to realize selective imaging and on‐demand photodynamic ablation of bacteria is of great scientific and practical interests for precise bacteria diagnosis and treatment. Herein, HClO‐activatable theranostic nanoprobes, DTF‐FFP NPs, for image‐guided bacterial ablation in phagocytes are introduced. DTF‐FFP NPs are prepared by nanoprecipitation of an HClO‐responsive near‐infrared molecule FFP and an efficient PS DTF with aggregation‐induced emission characteristic using an amphiphilic polymer Pluronic F127 as the encapsulation matrix. As an energy acceptor, FFP can quench both fluorescence and production of reactive oxygen species (ROS) of DTF, thus eliminating the phototoxicity of DTF‐FFP NPs in normal cells and tissues. Once delivered to the infection sites, DTF‐FFP NPs light up with red fluorescence and efficiently generate ROS owing to the degradation of FFP by the stimulated release of HClO in phagocytes. The selective activation of fluorescence and photosensitization is successfully confirmed by both in vitro and in vivo results, demonstrating the effectiveness and theranostic potential of DTF‐FFP NPs in precise bacterial therapy.
- 13 July 2020
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 32 (15) , 6437-6443
Binary Organic Nanoparticles with Bright Aggregation-Induced Emission for Three-Photon Brain Vascular Imaging
- 13 July 2020
- Published by American Chemical Society (ACS) in Chemistry of Materials
- Vol. 32 (15) , 6437-6443
Binary Organic Nanoparticles with Bright Aggregation-Induced Emission for Three-Photon Brain Vascular Imaging
- 9 April 2020
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 31 (5) , 1268-1278
Reprogramming Tumor Microenvironment with Photothermal Therapy
Tumor microenvironment significantly influences cancer progression and therapeutic response. Reprogramming of tumor microenvironment emerges as a strategy to assist conventional cancer treatment. In recent years, photothermal therapy has received considerable attention owing to its noninvasiveness, high temporal-spatial resolution and minimal drug resistance. Apart from ablating cancer cells by generating heat upon light irradiation, photothermal therapy can also affect tumor microenvironment, such as disrupting tumor extracellular matrix and tumor vasculature. Moreover, cancer cell death by hyperthermia could potentially activate the immune system to fight against tumor. In this article, we focus on the recent progress of photothermal therapy based on tumor microenvironment remodeling, aiming to better guide the design of nanoparticles for cancer photo-immunotherapy.
- 9 April 2020
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 31 (5) , 1268-1278
Reprogramming Tumor Microenvironment with Photothermal Therapy
Tumor microenvironment significantly influences cancer progression and therapeutic response. Reprogramming of tumor microenvironment emerges as a strategy to assist conventional cancer treatment. In recent years, photothermal therapy has received considerable attention owing to its noninvasiveness, high temporal-spatial resolution and minimal drug resistance. Apart from ablating cancer cells by generating heat upon light irradiation, photothermal therapy can also affect tumor microenvironment, such as disrupting tumor extracellular matrix and tumor vasculature. Moreover, cancer cell death by hyperthermia could potentially activate the immune system to fight against tumor. In this article, we focus on the recent progress of photothermal therapy based on tumor microenvironment remodeling, aiming to better guide the design of nanoparticles for cancer photo-immunotherapy.
- 26 March 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (8) , 5772-5779
Specific Near-Infrared Probe for Ultrafast Imaging of Lysosomal β-Galactosidase in Ovarian Cancer Cells
Reactivity based fluorescent probes have been widely investigated as a powerful and noninvasive tool for disease diagnosis in recent years. β-galactosidase (β-gal), one of the typical lysosomal glycosidases, is reported to be a vital biomarker overexpressed in primary ovarian cancer cells. Fluorescent probes with excellent performance for endogenous β-gal detection offer a unique option for visualization and diagnosis of primary ovarian cancers. Herein, a near-infrared fluorescent probe Lyso-Gal with lysosome-targeting ability was developed for lysosomal β-gal detection and imaging in ovarian cancer cells (SKOV-3 cells). Lyso-Gal exhibits weak fluorescence in aqueous solution but emits bright NIR fluorescence at 730 nm after incubation with β-gal. Highly selective imaging of ovarian cancer cells has been achieved upon incubation with Lyso-Gal for only 1 minute. The detection time is extremely short. In comparison with a similar hemicyanine probe Hx-Gal without lysosome-targeting ability, Lyso-Gal realizes endogenous β-gal visualization in lysosomes and shows brighter fluorescence than Hx-Gal in SKOV-3 cells. This work demonstrates the potential of Lyso-Gal for detection of primary ovarian cancer cells by using β-gal as the biomarker.
- 26 March 2020
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 92 (8) , 5772-5779
Specific Near-Infrared Probe for Ultrafast Imaging of Lysosomal β-Galactosidase in Ovarian Cancer Cells
Reactivity based fluorescent probes have been widely investigated as a powerful and noninvasive tool for disease diagnosis in recent years. β-galactosidase (β-gal), one of the typical lysosomal glycosidases, is reported to be a vital biomarker overexpressed in primary ovarian cancer cells. Fluorescent probes with excellent performance for endogenous β-gal detection offer a unique option for visualization and diagnosis of primary ovarian cancers. Herein, a near-infrared fluorescent probe Lyso-Gal with lysosome-targeting ability was developed for lysosomal β-gal detection and imaging in ovarian cancer cells (SKOV-3 cells). Lyso-Gal exhibits weak fluorescence in aqueous solution but emits bright NIR fluorescence at 730 nm after incubation with β-gal. Highly selective imaging of ovarian cancer cells has been achieved upon incubation with Lyso-Gal for only 1 minute. The detection time is extremely short. In comparison with a similar hemicyanine probe Hx-Gal without lysosome-targeting ability, Lyso-Gal realizes endogenous β-gal visualization in lysosomes and shows brighter fluorescence than Hx-Gal in SKOV-3 cells. This work demonstrates the potential of Lyso-Gal for detection of primary ovarian cancer cells by using β-gal as the biomarker.
- 4 November 2019
- Published by Wiley in Advanced Functional Materials
- Vol. 30 (1)
Nanostructural Control Enables Optimized Photoacoustic–Fluorescence–Magnetic Resonance Multimodal Imaging and Photothermal Therapy of Brain Tumor
The performance of current multimodal imaging contrast agents is often constrained by the tunability of nanomaterial structural design. Herein, the influence of nanostructure on the overall imaging performance of a composite nanomaterial for multimodal imaging of brain tumors is studied. Newly designed near‐infrared molecules (TC1) are encapsulated into nanocomposites with ultrasmall iron oxide nanoparticles (UIONPs), forming stable nanoagents for multimodal imaging and photothermal therapy (PTT). Through a modified nanoprecipitation method, the synthesis of nanocomposites denoted as HALF is realized, in which UIONPs are restricted to half of the nanosphere. Such a unique nanostructure that physically separates TC1 and UIONPs is found with capabilities of mitigating fluorescence quenching, preserving the good performance of photoacoustic imaging, and enhancing the magnetic resonance imaging signals. Decorated with a peptide ligand cRGD for better brain tumor targeting, HALF‐cRGD is evaluated both in vitro and in vivo as imaging contrast agents and photothermal therapeutic agents. The good imaging performance and PTT effect of HALF‐cRGD in mice models indicate that the rational design and control of nanostructures could optimize multimodal imaging performance using the same components.
- 4 November 2019
- Published by Wiley in Advanced Functional Materials
- Vol. 30 (1)
Nanostructural Control Enables Optimized Photoacoustic–Fluorescence–Magnetic Resonance Multimodal Imaging and Photothermal Therapy of Brain Tumor
The performance of current multimodal imaging contrast agents is often constrained by the tunability of nanomaterial structural design. Herein, the influence of nanostructure on the overall imaging performance of a composite nanomaterial for multimodal imaging of brain tumors is studied. Newly designed near‐infrared molecules (TC1) are encapsulated into nanocomposites with ultrasmall iron oxide nanoparticles (UIONPs), forming stable nanoagents for multimodal imaging and photothermal therapy (PTT). Through a modified nanoprecipitation method, the synthesis of nanocomposites denoted as HALF is realized, in which UIONPs are restricted to half of the nanosphere. Such a unique nanostructure that physically separates TC1 and UIONPs is found with capabilities of mitigating fluorescence quenching, preserving the good performance of photoacoustic imaging, and enhancing the magnetic resonance imaging signals. Decorated with a peptide ligand cRGD for better brain tumor targeting, HALF‐cRGD is evaluated both in vitro and in vivo as imaging contrast agents and photothermal therapeutic agents. The good imaging performance and PTT effect of HALF‐cRGD in mice models indicate that the rational design and control of nanostructures could optimize multimodal imaging performance using the same components.